Treatment for at least three years with Yorvipath (palopegteriparatide), an approved daily hormone replacement therapy used to help manage blood calcium levels in adults with hypoparathyroidism, led to sustained improvements in calcium control for patients taking part in a clinical trial. New results from the Phase 3 study,…
Discussion
 “What you have caught on film is captured forever. … It remembers little things, long after you have forgotten everything.” — Aaron Siskind While standing outdoors surrounded by nature, I watched the leaves move in the breeze and felt drawn to photograph golden petals in the sunlight. In that moment,…
Discussion
“It’s like déjà vu all over again.” — Yogi Berra Getting on a plane recently brought back a rush of familiar feelings. I remembered 2019, when I took this same flight from Florida to New York City for my first clinical trial appointment. I felt like I was reliving the…
Discussion
June is one of my favorite parts of the year. In addition to it being Pride Month, June started with World Hypoparathyroidism Awareness Day on the first. This month, two of the communities I advocate for come together. My life goal is to live authentically out loud, as…
Get regular updates to your inbox.
